Ureteroscopic and percutaneous management of upper tract urothelial carcinoma (UTUC): systematic review

Mark L Cutress, Grant D Stewart, Paimaun Zakikhani, Simon Phipps, Ben G Thomas, David A Tolley

Research output: Contribution to journalArticlepeer-review

Abstract / Description of output

What's known on the subject? and What does the study add? Endoscopic management of upper tract urothelial carcinoma (UTUC) using either ureteroscopy and laser ablation, or percutaneous resection, is a management option for treating selected low-grade tumours with favourable characteristics. However, the evidence base for such practice is relatively weak, as the reported experience is mainly limited to small case series (level of evidence 4), or non-randomised comparative studies that are unmatched for tumour stage (level of evidence 3b), with variability of follow-up duration and reported outcome measures. The present systematic review comprehensively reviews the outcomes of all studies of endoscopic management of UTUC, including the role of topical adjuvant therapy. It establishes for the first time a structured reference for endoscopic management of UTUC, and is a foundation for further clinical studies.
Original languageEnglish
Pages (from-to)614-28
Number of pages15
JournalBJU International
Volume110
Issue number5
DOIs
Publication statusPublished - Sept 2012

Keywords / Materials (for Non-textual outputs)

  • Antibiotics, Antineoplastic
  • BCG Vaccine
  • Biopsy
  • Carcinoma, Transitional Cell
  • Chemotherapy, Adjuvant
  • Disease Progression
  • Humans
  • Mitomycin
  • Neoplasm Recurrence, Local
  • Nephrectomy
  • Postoperative Complications
  • Risk Factors
  • Treatment Outcome
  • Ureter
  • Ureteroscopy
  • Urologic Neoplasms
  • Urothelium

Fingerprint

Dive into the research topics of 'Ureteroscopic and percutaneous management of upper tract urothelial carcinoma (UTUC): systematic review'. Together they form a unique fingerprint.

Cite this